First Trust Advisors LP decreased its position in shares of Colfax Corp (NYSE:CFX) by 1.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 150,599 shares of the industrial products company’s stock after selling 2,131 shares during the quarter. First Trust Advisors LP owned 0.12% of Colfax worth $5,967,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently modified their holdings of CFX. Victory Capital Management Inc. grew its stake in shares of Colfax by 54.9% during the 4th quarter. Victory Capital Management Inc. now owns 4,487,041 shares of the industrial products company’s stock worth $177,776,000 after purchasing an additional 1,589,485 shares during the period. Wells Fargo & Company MN grew its stake in shares of Colfax by 97.2% during the 3rd quarter. Wells Fargo & Company MN now owns 2,959,647 shares of the industrial products company’s stock worth $123,239,000 after purchasing an additional 1,458,683 shares during the period. Oakview Capital Management L.P. acquired a new stake in shares of Colfax during the 3rd quarter worth approximately $16,570,000. Wedge Capital Management L L P NC grew its stake in shares of Colfax by 26.1% during the 4th quarter. Wedge Capital Management L L P NC now owns 1,667,364 shares of the industrial products company’s stock worth $66,061,000 after purchasing an additional 344,946 shares during the period. Finally, PenderFund Capital Management Ltd. acquired a new stake in shares of Colfax during the 4th quarter worth approximately $10,091,000. 77.63% of the stock is currently owned by institutional investors and hedge funds.
In other Colfax news, CEO Ian Brander sold 1,240 shares of the firm’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $33.46, for a total value of $41,490.40. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP A. Lynne Puckett sold 7,270 shares of the firm’s stock in a transaction on Tuesday, January 16th. The shares were sold at an average price of $42.01, for a total value of $305,412.70. The disclosure for this sale can be found here. Insiders sold a total of 64,295 shares of company stock worth $2,463,601 in the last 90 days. 10.60% of the stock is currently owned by insiders.
Shares of Colfax Corp (NYSE:CFX) traded down $0.14 during mid-day trading on Wednesday, reaching $33.17. The company’s stock had a trading volume of 956,207 shares, compared to its average volume of 885,046. The company has a quick ratio of 1.49, a current ratio of 1.89 and a debt-to-equity ratio of 0.28. The stock has a market cap of $4,070.00, a price-to-earnings ratio of -53.73, a P/E/G ratio of 1.18 and a beta of 1.32. Colfax Corp has a 12 month low of $31.26 and a 12 month high of $43.29.
Colfax (NYSE:CFX) last announced its quarterly earnings data on Tuesday, February 6th. The industrial products company reported $0.45 earnings per share for the quarter, beating analysts’ consensus estimates of $0.44 by $0.01. The company had revenue of $874.00 million for the quarter, compared to analyst estimates of $894.02 million. Colfax had a return on equity of 5.95% and a net margin of 4.28%. The firm’s revenue for the quarter was up 7.6% on a year-over-year basis. During the same quarter last year, the firm posted $0.46 EPS. equities research analysts predict that Colfax Corp will post 2.12 earnings per share for the current year.
CFX has been the topic of a number of analyst reports. Barclays started coverage on shares of Colfax in a research note on Thursday, February 15th. They set an “underweight” rating on the stock. Stifel Nicolaus reissued a “buy” rating and issued a $44.00 price target on shares of Colfax in a research note on Monday, December 11th. Longbow Research raised shares of Colfax from a “neutral” rating to a “buy” rating in a research note on Tuesday, November 21st. Argus reissued a “buy” rating and issued a $33.36 price target (down previously from $40.00) on shares of Colfax in a research note on Thursday, February 22nd. Finally, Oppenheimer reissued a “hold” rating on shares of Colfax in a research note on Thursday, November 30th. Three analysts have rated the stock with a sell rating, five have given a hold rating and nine have given a buy rating to the company. Colfax presently has a consensus rating of “Hold” and an average price target of $42.74.
TRADEMARK VIOLATION NOTICE: This story was originally published by The Lincolnian Online and is owned by of The Lincolnian Online. If you are viewing this story on another website, it was illegally copied and republished in violation of United States & international trademark & copyright law. The original version of this story can be viewed at https://www.thelincolnianonline.com/2018/03/14/first-trust-advisors-lp-cuts-holdings-in-colfax-corp-cfx.html.
Colfax Corporation is an industrial manufacturing and engineering company. The Company provides air and gas handling, and fabrication technology products and services. The Company’s segments include Air and Gas handling, and Fabrication Technology. The Air and Gas Handling segment supplies a range of gas handling products, including heavy-duty centrifugal and axial fans, rotary heat exchangers, gas compressors, pumps and certain related products, as well as aftermarket services.
Receive News & Ratings for Colfax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colfax and related companies with MarketBeat.com's FREE daily email newsletter.